Weng L. Ng

Liverpool, NSW 2170, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications

Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical Trials.

Measuring What Matters: RECIST Response Does Not Predict HRQoL in Early-Phase Clinical Trials.

Journal: Cancers
Published: February 06, 2026

Healthcare professionals' perspectives on the barriers and enablers of cancer clinical trial participation among Arabic-speaking cancer patients in Australia: a qualitative study.

Healthcare professionals' perspectives on the barriers and enablers of cancer clinical trial participation among Arabic-speaking cancer patients in Australia: a qualitative study.

Journal: Trials
Published: November 05, 2025

Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort Study.

Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort Study.

Journal: JCO oncology practice
Published: November 03, 2025

Multicentre study comparing ab-interno canaloplasty and trabecular micro-bypass stent in primary open-angle glaucoma.

Multicentre study comparing ab-interno canaloplasty and trabecular micro-bypass stent in primary open-angle glaucoma.

Journal: Eye (London, England)
Published: October 02, 2025

Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line setting.

Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line setting.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: June 27, 2025

Prospective assessment of health-related quality of life in early phase oncology clinical trials: PEARLER.

Prospective assessment of health-related quality of life in early phase oncology clinical trials: PEARLER.

Journal: JNCI cancer spectrum
Published: June 17, 2025

Inclusion of Older Adults in Early-Phase Cancer Clinical Trials: Safety, Efficacy and a Way Forward.

Inclusion of Older Adults in Early-Phase Cancer Clinical Trials: Safety, Efficacy and a Way Forward.

Journal: Drugs & aging
Published: May 30, 2025

Application of Generative Artificial Intelligence for Physician and Patient Oncology Letters-AI-OncLetters.

Application of Generative Artificial Intelligence for Physician and Patient Oncology Letters-AI-OncLetters.

Journal: JCO clinical cancer informatics
Published: May 02, 2025

Prognostic Value of LC3A Protein Expression Patterns in Rectal Cancer Tumors.

Prognostic Value of LC3A Protein Expression Patterns in Rectal Cancer Tumors.

Journal: Cancers
Published: March 10, 2025

Evaluating patient diversity in early phase clinical trials in Australia through a prospective multicenter nonrandomized cohort study.

Evaluating patient diversity in early phase clinical trials in Australia through a prospective multicenter nonrandomized cohort study.

Journal: JNCI cancer spectrum
Published: December 23, 2024

Retrospective audit reviewing accuracy of clinical diagnosis of geographic atrophy in a single centre private tertiary retinal practice in Australia.

Retrospective audit reviewing accuracy of clinical diagnosis of geographic atrophy in a single centre private tertiary retinal practice in Australia.

Journal: Scientific reports
Published: December 15, 2024

RAS-variant allele frequency as a potential prognostic marker of overall survival in patients with metastatic colorectal cancer.

RAS-variant allele frequency as a potential prognostic marker of overall survival in patients with metastatic colorectal cancer.

Journal: Cancer treatment and research communications
Published: September 18, 2024
Showing 1-12 of 70

Last Updated: 09/26/2026